Does Radioactive Iodine Worsen Thyroid Eye Disease?

Yes, radioactive iodine (RAI) can trigger or worsen thyroid eye disease (TED), also known as thyrotoxic exophthalmos ^[1]. However, this risk varies from person to person and can often be managed. When RAI is used to treat Graves’ disease, it damages the overactive thyroid gland, which is thought to release thyroid antigens into the bloodstream ^[2][3]. This may cause your immune system to temporarily ramp up its production of autoantibodies that can activate the tissues around your eyes ^[4]. Fortunately, doctors can reduce this risk by prescribing prophylactic (preventative) oral steroids for you to take around the time of your RAI treatment ^[5].

⚠️ URGENT WARNING SIGNS
Contact your ophthalmologist immediately or seek emergency care if you experience any of the following, as they could indicate sight-threatening complications ^[6][7]:

• New or rapidly worsening loss or blurring of vision
• Colors looking “washed out” or less vibrant
• A new missing part of your visual field
• Severe eye pain
• Inability to completely close your eyelids (corneal exposure)

Why Radioactive Iodine May Affect the Eyes

In Graves’ disease, your immune system mistakenly produces TSH-receptor antibodies (TRAb) that stimulate your thyroid gland to overproduce thyroid hormone ^[8]. These same antibodies are involved in activating orbital fibroblasts (cells behind the eyes), leading to the characteristic inflammation, tissue remodeling, and swelling of thyroid eye disease ^[9].

When you receive radioactive iodine, the radiation gradually destroys the overactive thyroid cells. As these cells break down, it is thought that they release stored thyroid proteins and antigens into your bloodstream ^[2][3]. In response, your immune system may produce an even higher number of TSH-receptor antibodies, which usually peak a few months after the treatment ^[4][10]. This antibody rise can trigger or worsen inflammation in the muscles and fatty tissues behind your eyes ^[5][10].

Furthermore, as the RAI destroys the thyroid gland, your thyroid hormone levels will drop. If they drop too low and you become hypothyroid (underactive thyroid), this drastic shift in hormone levels can also exacerbate your eye disease ^[11][12]. Prompt monitoring of thyroid function—typically starting 4 to 6 weeks after treatment—is critical to ensure hormone levels remain stable ^[13].

Reducing the Risk with Steroids

Because the risk of TED worsening after RAI is well known, endocrinologists and ophthalmologists have strategies to protect your eyes. A common approach is a short course of oral corticosteroids, such as prednisone, taken around the time of your RAI treatment.

Research shows that prophylactic steroids significantly reduce—though do not entirely eliminate—the combined risk of your eye disease developing or worsening ^[5][10]. The steroids are thought to work by suppressing the immune system enough to blunt the antibody spike ^[10].

However, steroids are not appropriate for everyone. The decision to use them depends on whether your TED is active or inactive, the severity of your symptoms, and your individual risk factors ^[11][6]. Steroids also carry their own risks, such as elevated blood sugar, mood changes, increased infection risk, and blood pressure effects. You should only take them under strict medical supervision, and the dose and duration must be individualized by your doctor.

Who Is Most at Risk?

Not everyone who receives RAI will experience worsening eye symptoms. Your risk is higher if you:

• Smoke tobacco: Combustible tobacco smoking is one of the strongest modifiable risk factors for developing TED and for having it worsen after RAI ^[11][12]. Quitting smoking before treatment is highly recommended.
• Have active TED: Disease activity refers to current inflammation (such as redness, eye pain, or recent swelling). If your eye symptoms are active, they are more likely to flare up than if the disease is inactive (stable and non-inflamed) ^[11][14].
• Have high antibody levels: Very high levels of TSH-receptor antibodies before treatment indicate a more aggressive autoimmune response ^[11].

Considering Alternative Treatments

Treatment decisions depend heavily on the severity and activity of your eye disease. If you have moderate-to-severe and currently active TED, professional guidelines generally recommend avoiding radioactive iodine altogether ^[11][6].

Instead, your medical team may recommend managing your hyperthyroidism with anti-thyroid medications (such as methimazole) or through surgical removal of the thyroid gland (thyroidectomy) ^[11][15]. While these alternatives do not cause the same spike in antibodies, they carry their own medical and surgical risks, and they do not directly treat the eye disease itself. All three options are considered acceptable if your TED is inactive ^[11].

It is crucial that your endocrinologist and an ophthalmologist work together to evaluate your eye status before deciding if radioactive iodine is the safest path forward for you ^[16].